Pall (MEX:PLL) ROCE % : 20.09% (As of Apr. 2015)

View and export this data going back to . Start your Free Trial

What is Pall ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pall's annualized ROCE % for the quarter that ended in Apr. 2015 was 20.09%.

Pall ROCE % Historical Data

The historical data trend for Pall's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pall ROCE % Chart

Pall Annual Data

Trend

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Jul14

ROCE %

Get a 7-Day Free Trial

15.18

17.86

17.00

16.38

17.64

Pall Quarterly Data
	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15
ROCE %	Get a 7-Day Free Trial															15.72	22.79	19.41	19.86	20.09

Pall ROCE % Calculation

Pall's annualized ROCE % for the fiscal year that ended in Jul. 2014 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jul. 2014 )		(A: Jul. 2013 )		(A: Jul. 2014 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jul. 2014 )		(A: Jul. 2013 )		(A: Jul. 2014 )
	=	6326.743	/	( ( (44650.291 - 9373.666)	+	(50995.715 - 14529.54) )	/ 2 )
	=	6326.743	/	( (35276.625	+	36466.175)	/ 2 )
	=	6326.743	/	35871.4
	=	17.64 %

Pall's ROCE % of for the quarter that ended in Apr. 2015 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Apr. 2015 )		(Q: Jan. 2015 )		(Q: Apr. 2015 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Apr. 2015 )		(Q: Jan. 2015 )		(Q: Apr. 2015 )
	=	7357.9	/	( ( (55036.96 - 19464.681)	+	(57547.509 - 19886.513) )	/ 2 )
	=	7357.9	/	( ( 35572.279	+	37660.996 )	/ 2 )
	=	7357.9	/	36616.6375
	=	20.09 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2015) EBIT data.

Pall (MEX:PLL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pall ROCE % Related Terms

Thank you for viewing the detailed overview of Pall's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pall (MEX:PLL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Pall Corporation (MEX:PLL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.pall.com

Pall Corporation is a New York corporation incorporated on July 31, 1946. The Company supplies filtration, separation and purification technologies. Its products are used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases. Its serves its customers through two businesses: Life Sciences and Industrial. The Life Sciences business group is engaged in developing, manufacturing and selling products to customers in the BioPharmaceutical, Food & Beverage and Medical markets. The Industrial business group is engaged in developing, manufacturing and selling products to customers in the Process Technologies, Aerospace and Microelectronics markets. The Life Sciences technologies facilitate the process of drug discovery, development, regulatory validation and production, and are used in research laboratories, and the pharmaceutical and biotechnology industries. It also supplies products and technologies for food and beverage industries and in hospitals at the point of patient care. The Industrial segment provides enabling and process-enhancing technologies throughout the industrial marketplace. These include the Process Technologies, Aerospace and Microelectronics markets. It has the capability to provide customers with integrated solutions using its proprietary consumable filtration products for their process fluids. The Company's competition varies by product and application. Its competitors in the BioPharmaceuticals market include Merck Millipore (a division of Merck KGaA), The Sartorius Group and GE Healthcare (a unit of General Electric Company ("GE")). Its competitors in the Food & Beverage market include 3M Purification, Pentair, Inc., Filtrox Group, The Sartorius Group, Eaton Corporation and Parker Domnick Hunter (a division of Parker Hannifin). Its competitors in the Medical market include Merck Millipore, GE Healthcare, Teleflex Incorporated, Covidien plc and Intersurgical, Ltd. Its competitors in the Process Technologies market include CLARCOR Inc., Donaldson Company, Inc., Parker Hannifin Corporation, HYDAC International GmbH, GE Infrastructure (a unit of GE), Pentair, Inc., 3M Purification, U.S. Filter (a unit of Siemens AG) and ESCO Technologies Inc. Its competitors in the Aerospace market include Donaldson Company, Inc. and ESCO Technologies Inc. Its competitors in the Microelectronics market include Entegris, Inc., Parker Hannifin Corporation and Mott Corporation. The Company is subject to competition in all of the global markets in which it operates.